Debate: Follicular Lymphoma and the Role of Maintenance Therapy
This information was originally presented on September 20, 2014, at the NCCN 9th Annual Congress: Hematologic Malignancies™ held in New York, New York.
This activity is designed to meet the educational needs of hematologists, oncologists, nurses, pharmacists, and other health care professionals who manage patients with hematologic malignancies.
Following this activity, participants should be able to:
- Identify appropriate patients who could be candidates for maintenance therapy
Richard I. Fisher, MD
Fox Chase Cancer Center
Andrew D. Zelenetz, MD, PhD
Memorial Sloan Kettering Cancer Center
- 0.50 Participation
- 0.53 Nurse
- 0.50 Pharmacist
- 0.50 Physician